IS4813A - Bensýl íden-Laktam afleiður, framleiðsla þeirra og notkun þeirra sem valvís mót-/gerandefni fyrir 5-HT1A- og/eða 5-HT1D- viðtaka - Google Patents

Bensýl íden-Laktam afleiður, framleiðsla þeirra og notkun þeirra sem valvís mót-/gerandefni fyrir 5-HT1A- og/eða 5-HT1D- viðtaka

Info

Publication number: IS4813A
Authority: IS; Iceland
Prior art keywords: ht1a; preparation; selective antagonists; lactam derivatives; ht1d receptors
Prior art date: 1996-03-29

Application number

IS4813A

Other languages

English (en)

Inventor

R. Howard Harry

Original Assignee

Pfizer Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-03-29

Filing date

1998-07-29

Publication date

1998-07-29

1998-07-29 Application filed by Pfizer Inc filed Critical Pfizer Inc

1998-07-29 Publication of IS4813A publication Critical patent/IS4813A/is

Links

102100022738 5-hydroxytryptamine receptor 1A Human genes 0.000 title 1
101150015707 HTR1A gene Proteins 0.000 title 1
101100321769 Takifugu rubripes htr1d gene Proteins 0.000 title 1
239000005557 antagonist Substances 0.000 title 1
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/38—2-Pyrrolones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Psychology (AREA)
Psychiatry (AREA)
Child & Adolescent Psychology (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Pyrrole Compounds (AREA)
Indole Compounds (AREA)
Quinoline Compounds (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)

IS4813A 1996-03-29 1998-07-29 Bensýl íden-Laktam afleiður, framleiðsla þeirra og notkun þeirra sem valvís mót-/gerandefni fyrir 5-HT1A- og/eða 5-HT1D- viðtaka IS4813A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US1513496P	1996-03-29	1996-03-29
PCT/IB1997/000076 WO1997036867A1 (en)	1996-03-29	1997-02-03	Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors

Publications (1)

Publication Number	Publication Date
IS4813A true IS4813A (is)	1998-07-29

Family

ID=21769713

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS4813A IS4813A (is)	1996-03-29	1998-07-29	Bensýl íden-Laktam afleiður, framleiðsla þeirra og notkun þeirra sem valvís mót-/gerandefni fyrir 5-HT1A- og/eða 5-HT1D- viðtaka

Country Status (39)

Country	Link
US (2)	US6462048B2 (is)
EP (1)	EP0894085B1 (is)
JP (1)	JP3118467B2 (is)
KR (1)	KR100305071B1 (is)
CN (1)	CN1128788C (is)
AP (1)	AP824A (is)
AR (1)	AR006390A1 (is)
AT (1)	ATE302182T1 (is)
AU (1)	AU706839B2 (is)
BG (1)	BG64176B1 (is)
BR (1)	BR9708581A (is)
CA (1)	CA2249603A1 (is)
CO (1)	CO4650033A1 (is)
CZ (1)	CZ293628B6 (is)
DE (1)	DE69733996T2 (is)
DZ (1)	DZ2198A1 (is)
EA (1)	EA001485B1 (is)
ES (1)	ES2246058T3 (is)
HN (1)	HN1997000023A (is)
HR (1)	HRP970175A2 (is)
HU (1)	HUP9902160A3 (is)
ID (1)	ID17781A (is)
IL (1)	IL125377A (is)
IS (1)	IS4813A (is)
MA (1)	MA26425A1 (is)
MY (1)	MY118498A (is)
NO (1)	NO312957B1 (is)
NZ (1)	NZ325914A (is)
OA (1)	OA10879A (is)
PL (1)	PL329170A1 (is)
SK (1)	SK131498A3 (is)
TN (1)	TNSN97056A1 (is)
TR (1)	TR199801929T2 (is)
TW (1)	TW413679B (is)
UA (1)	UA70284C2 (is)
UY (1)	UY24498A1 (is)
WO (1)	WO1997036867A1 (is)
YU (1)	YU11997A (is)
ZA (1)	ZA972690B (is)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH041367U (is) *	1990-04-13	1992-01-08
US6147106A (en)	1997-08-20	2000-11-14	Sugen, Inc.	Indolinone combinatorial libraries and related products and methods for the treatment of disease
US5880141A (en) *	1995-06-07	1999-03-09	Sugen, Inc.	Benzylidene-Z-indoline compounds for the treatment of disease
US6906093B2 (en)	1995-06-07	2005-06-14	Sugen, Inc.	Indolinone combinatorial libraries and related products and methods for the treatment of disease
US6696448B2 (en)	1996-06-05	2004-02-24	Sugen, Inc.	3-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors
UA56185C2 (uk)	1996-09-30	2003-05-15	Пфайзер Інк.	Аралкіл- та аралкіліденгетероциклічні лактами та іміди, фармацевтична композиція та спосіб лікування
US6423708B1 (en) *	1996-09-30	2002-07-23	Pfizer Inc	Aralkyl and aralkylidene heterocyclic lactams and imides
GB9718913D0 (en)	1997-09-05	1997-11-12	Glaxo Group Ltd	Substituted oxindole derivatives
US6531502B1 (en)	1998-01-21	2003-03-11	Sugen, Inc.	3-Methylidenyl-2-indolinone modulators of protein kinase
DE19830201A1 (de) *	1998-07-07	2000-01-13	Boehringer Ingelheim Pharma	Mittel mit antidepressiver Wirkung
CA2301899C (en) *	1998-07-27	2008-11-18	Boehringer Ingelheim Pharma Kg	Agent with an antidepressant activity
GB9904933D0 (en)	1999-03-04	1999-04-28	Glaxo Group Ltd	Compounds
US6492398B1 (en)	1999-03-04	2002-12-10	Smithkline Beechman Corporation	Thiazoloindolinone compounds
US6624171B1 (en)	1999-03-04	2003-09-23	Smithkline Beecham Corporation	Substituted aza-oxindole derivatives
DE60013751T2 (de) *	1999-12-29	2005-09-29	Pfizer Products Inc., Groton	Optisch aktive 3-((2-piperazinyl-phenyl)methyl)-1-(4-(trifluoromethyl)-phenyl)-2-pyrrolidinone als selektive 5-HT1D Rezeptor Antagonisten
JP3663382B2 (ja)	2000-02-15	2005-06-22	スージェン・インコーポレーテッド	ピロール置換２−インドリノン蛋白質キナーゼ阻害剤
US6620818B1 (en)	2000-03-01	2003-09-16	Smithkline Beecham Corporation	Method for reducing the severity of side effects of chemotherapy and/or radiation therapy
AR042586A1 (es)	2001-02-15	2005-06-29	Sugen Inc	3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
BR0213185A (pt)	2001-10-10	2004-09-14	Sugen Inc	Derivados de 3-[4-(heterociclila substituìda)-pirrol-2-ilmetilideno]2-indolinona como inibidores de cinase
EP1469850B1 (en)	2002-01-02	2013-01-02	Versi Group, LLC	Method of treating sexual dysfunctions with delta opioid receptor agonist compounds
TWI263497B (en) *	2002-03-29	2006-10-11	Lilly Co Eli	Pyridinoylpiperidines as 5-HT1F agonists
US7671072B2 (en) *	2003-11-26	2010-03-02	Pfizer Inc.	Aminopyrazole derivatives as GSK-3 inhibitors
WO2005082372A1 (en) *	2004-01-29	2005-09-09	Pfizer Products Inc.	COMBINATION OF γ-AMINOBUTYRIC ACID MODULATORS AND 5-HT 1B RECEPTOR ANTAGONISTS
KR20060124770A (ko)	2004-03-17	2006-12-05	화이자 프로덕츠 인코포레이티드	벤질(이덴)-락탐 유도체
MXPA06013163A (es) *	2004-05-11	2007-02-13	Pfizer Prod Inc	Combinacion de antipsicoticos atipicos y antagonistas del receptor 5-ht1b.
BRPI0511419A (pt) *	2004-05-21	2007-12-04	Pfizer Prod Inc	derivado de lactama de pirazinilmetila
MXPA06014473A (es) *	2004-06-25	2007-03-01	Pfizer Prod Inc	Piridil piperazinas para el tratamiento de trastornos de sistema nervioso central.
ES2371927T3 (es) *	2005-01-13	2012-01-11	Ge Healthcare Limited	Compuestos de bencil-lactama marcados con 11c y su uso como agentes de obtención de imágenes.
WO2006106416A1 (en) *	2005-04-08	2006-10-12	Pfizer Products Inc.	PYRIDIL-LACTAMS AND THEIR USE 5 -HTl RECEPTORS LIGAN
WO2006136945A1 (en) *	2005-06-17	2006-12-28	Pfizer Products Inc.	METABOLITES OF 1&lowbar; [&lowbar;6- (1-ETHYL-l-HYDROXY-PROPYL) -PYRIDIN-3-YL] -3- [2- (4-METHYL-PIPERAZIN-I-YL) -BE NZYL] -PYRR0LIDIN-2-0NE AS SERATONIN RECEPTOR ANTAGONISTS
WO2007012964A1 (en) *	2005-07-25	2007-02-01	Pfizer Products Inc.	Preparation of alkylpiperazinylphenyl compounds by classical resolution
WO2007026219A2 (en) *	2005-08-31	2007-03-08	Pfizer Products Inc.	Combinations of a 5-ht1b antagonist with a noradrenalin re-uptake inhibitor or a serotonin noradrenalin reutake inhibitor for treating cns conditions
WO2007026224A2 (en) *	2005-08-31	2007-03-08	Pfizer Products Inc.	5-ht1b antagonist composition for depression, anxiety and cognition
US20070096411A1 (en) *	2005-11-02	2007-05-03	Rempe Gary L Ii	Device for retaining a kneeling rider on a gliding board
US20140206667A1 (en)	2012-11-14	2014-07-24	Michela Gallagher	Methods and compositions for treating schizophrenia
RS63319B1 (sr) *	2015-09-02	2022-07-29	Trevena Inc	Jedinjenja koja modulišu delta-opioidni receptor, koja sadrže 6-člani aza-heterociklik, postupci njihove upotrebe i spravljanja
AU2018221148B2 (en)	2017-02-17	2022-05-05	Trevena, Inc.	5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
CN110446495B (zh)	2017-02-17	2023-09-05	特维娜有限公司	含有7元氮杂杂环的δ阿片受体调节化合物及其使用和制备方法
WO2020183011A1 (en)	2019-03-14	2020-09-17	Institut Curie	Htr1d inhibitors and uses thereof in the treatment of cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4078062A (en) *	1976-10-28	1978-03-07	E. R. Squibb & Sons, Inc.	Substituted 2H-1,4-benzothiazin-3(4H)-ones
JPS62116557A (ja) *	1985-11-15	1987-05-28	Takeda Chem Ind Ltd	置換ベンジルラクタム類
US5189179A (en) *	1990-08-29	1993-02-23	Merrell Dow Pharmaceuticals Inc.	Serotonin 5ht1a agonists
PT533268E (pt)	1991-09-18	2002-02-28	Glaxo Group Ltd	Derivados de benzanilida como antagonistas de 5-ht1d
DE69221309T2 (de) *	1991-10-11	1997-12-11	The Du Pont Merck Pharmaceutical Co., Wilmington, Del.	Cyclische harnstoffe und analoga verwendbar als retrovirale proteasehemmer
US5436246A (en)	1992-09-17	1995-07-25	Merrell Dow Pharmaceuticals Inc.	Serotonin receptor agents
GB9410512D0 (en) *	1994-05-25	1994-07-13	Smithkline Beecham Plc	Novel treatment
US5880141A (en) *	1995-06-07	1999-03-09	Sugen, Inc.	Benzylidene-Z-indoline compounds for the treatment of disease
US6467084B1 (en) *	1999-12-16	2002-10-15	Emware, Inc.	Systems and methods for reprogramming an embedded device with program code using relocatable program code

1997
- 1997-02-03 EA EA199800771A patent/EA001485B1/ru not_active IP Right Cessation
- 1997-02-03 HU HU9902160A patent/HUP9902160A3/hu unknown
- 1997-02-03 ES ES97900717T patent/ES2246058T3/es not_active Expired - Lifetime
- 1997-02-03 CN CN97193251A patent/CN1128788C/zh not_active Expired - Fee Related
- 1997-02-03 SK SK1314-98A patent/SK131498A3/sk unknown
- 1997-02-03 US US09/155,215 patent/US6462048B2/en not_active Expired - Fee Related
- 1997-02-03 AU AU13170/97A patent/AU706839B2/en not_active Ceased
- 1997-02-03 EP EP97900717A patent/EP0894085B1/en not_active Expired - Lifetime
- 1997-02-03 KR KR1019980707713A patent/KR100305071B1/ko not_active Expired - Fee Related
- 1997-02-03 CA CA002249603A patent/CA2249603A1/en not_active Abandoned
- 1997-02-03 IL IL12537797A patent/IL125377A/xx not_active IP Right Cessation
- 1997-02-03 NZ NZ325914A patent/NZ325914A/en unknown
- 1997-02-03 WO PCT/IB1997/000076 patent/WO1997036867A1/en not_active Ceased
- 1997-02-03 JP JP09535074A patent/JP3118467B2/ja not_active Expired - Fee Related
- 1997-02-03 TR TR1998/01929T patent/TR199801929T2/xx unknown
- 1997-02-03 CZ CZ19983052A patent/CZ293628B6/cs not_active IP Right Cessation
- 1997-02-03 PL PL97329170A patent/PL329170A1/xx unknown
- 1997-02-03 AT AT97900717T patent/ATE302182T1/de not_active IP Right Cessation
- 1997-02-03 BR BR9708581A patent/BR9708581A/pt not_active Application Discontinuation
- 1997-02-03 DE DE69733996T patent/DE69733996T2/de not_active Expired - Fee Related
- 1997-02-04 TW TW086101295A patent/TW413679B/zh active
- 1997-02-06 HN HN1997000023A patent/HN1997000023A/es unknown
- 1997-03-02 UA UA98095077A patent/UA70284C2/uk unknown
- 1997-03-13 CO CO97013714A patent/CO4650033A1/es unknown
- 1997-03-21 UY UY24498A patent/UY24498A1/es not_active IP Right Cessation
- 1997-03-25 AR ARP970101200A patent/AR006390A1/es not_active Application Discontinuation
- 1997-03-26 DZ DZ970045A patent/DZ2198A1/fr active
- 1997-03-26 TN TNTNSN97056A patent/TNSN97056A1/fr unknown
- 1997-03-26 MA MA24535A patent/MA26425A1/fr unknown
- 1997-03-26 HR HR60/015,134A patent/HRP970175A2/hr not_active Application Discontinuation
- 1997-03-27 ID IDP971025A patent/ID17781A/id unknown
- 1997-03-27 AP APAP/P/1997/000955A patent/AP824A/en active
- 1997-03-27 YU YU11997A patent/YU11997A/sh unknown
- 1997-03-27 ZA ZA972690A patent/ZA972690B/xx unknown
- 1997-03-28 MY MYPI97001340A patent/MY118498A/en unknown
1998
- 1998-07-29 IS IS4813A patent/IS4813A/is unknown
- 1998-09-16 OA OA9800170A patent/OA10879A/en unknown
- 1998-09-24 BG BG102791A patent/BG64176B1/bg unknown
- 1998-09-28 NO NO19984513A patent/NO312957B1/no unknown
2002
- 2002-08-15 US US10/219,692 patent/US6924289B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CZ293628B6 (cs)	2004-06-16
AP824A (en)	2000-04-28
TR199801929T2 (xx)	1998-12-21
KR100305071B1 (ko)	2001-12-12
US20020028821A1 (en)	2002-03-07
SK131498A3 (en)	2000-09-12
BR9708581A (pt)	1999-08-03
HUP9902160A2 (hu)	1999-11-29
CN1128788C (zh)	2003-11-26
IL125377A (en)	2005-07-25
YU11997A (sh)	1999-09-27
IL125377A0 (en)	1999-03-12
AP9700955A0 (en)	1997-04-30
TW413679B (en)	2000-12-01
ZA972690B (en)	1998-09-28
HN1997000023A (es)	1997-06-05
US6924289B2 (en)	2005-08-02
US20030027812A1 (en)	2003-02-06
JP3118467B2 (ja)	2000-12-18
ID17781A (id)	1998-01-29
JPH11506472A (ja)	1999-06-08
NO312957B1 (no)	2002-07-22
CO4650033A1 (es)	1998-09-03
HRP970175A2 (en)	1998-12-31
EP0894085A1 (en)	1999-02-03
DE69733996D1 (de)	2005-09-22
DE69733996T2 (de)	2006-07-20
HK1019446A1 (en)	2000-02-11
NO984513D0 (no)	1998-09-28
UY24498A1 (es)	2000-09-29
CN1214043A (zh)	1999-04-14
KR20000005083A (ko)	2000-01-25
BG64176B1 (bg)	2004-03-31
CZ305298A3 (cs)	1999-07-14
CA2249603A1 (en)	1997-10-09
AR006390A1 (es)	1999-08-25
AU1317097A (en)	1997-10-22
UA70284C2 (en)	2004-10-15
HUP9902160A3 (en)	2001-02-28
BG102791A (en)	1999-11-30
NO984513L (no)	1998-09-28
WO1997036867A1 (en)	1997-10-09
AU706839B2 (en)	1999-06-24
EA001485B1 (ru)	2001-04-23
TNSN97056A1 (fr)	2005-03-15
DZ2198A1 (fr)	2002-12-02
ES2246058T3 (es)	2006-02-01
EA199800771A1 (ru)	1999-06-24
OA10879A (en)	2001-10-05
MY118498A (en)	2004-11-30
EP0894085B1 (en)	2005-08-17
MA26425A1 (fr)	2004-12-20
NZ325914A (en)	1999-09-29
PL329170A1 (en)	1999-03-15
ATE302182T1 (de)	2005-09-15
US6462048B2 (en)	2002-10-08

Publication	Publication Date	Title
IS4813A (is)	1998-07-29	Bensýl íden-Laktam afleiður, framleiðsla þeirra og notkun þeirra sem valvís mót-/gerandefni fyrir 5-HT1A- og/eða 5-HT1D- viðtaka
AU4337699A (en)	1999-12-30	Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5HT4 receptors
IS2458B (is)	2008-11-15	Indólín-2-ón afleiður, framleiðsla og notkun þeirra sem mjaltavaka (ocytocin) viðtakabindlar
EE04721B1 (et)	2006-10-16	Fenüülksantiini derivaadid, nende valmistamismeetodid ja kasutamine
IT1313625B1 (it)	2002-09-09	Derivati benzimidazolonici aventi affinita' mista per i recettori diserotonina e dopamina.
NO20024281D0 (no)	2002-09-06	Indolderivater, fremgangsmåte for fremstilling av de samme og anvendelse derav
NO20021379D0 (no)	2002-03-20	Benzodiazepin-derivater, fremstilling og anvendelse derav
IS2076B (is)	2006-02-15	Asýl-píperasínil-pýrimídínafleiður, framleiðsla og notkun þeirra sem lyfja
NO20006138D0 (no)	2000-12-01	Substituerte indolinoner, fremstilling og anvendelse derav som medikamenter
IS5295A (is)	1999-12-10	Azetidínýlprópýlpíperidín afleiður, milliefni og notkun sem mótlyf gegn kínínhröðun
FI990134L (fi)	1999-03-24	Pyridatsino-(4,5-beta)-kinoliini-5-oksidijohdannaisia, niiden valmistus ja niiden käyttö glysiiniantagonisteina
HUP0101475A3 (en)	2003-01-28	4,5,6 and 7-indole and indoline derivatives, their preparation and use
EE03682B1 (et)	2002-04-15	Asendatud bensimidasooli derivaadid, protsessid nende valmistamiseks ning nende kasutamine
DK0819703T3 (da)	2004-11-01	Polymere glucanetherderivater, fremstilling og anvendelse deraf
NO971136D0 (no)	1997-03-12	Aminoalkyl- og acylaminoaklyleter, fremgangsmåte for fremstilling derav og anvendelse som bradykinin-reseptor antagonister
HUP0100926A3 (en)	2003-03-28	Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d4 receptor antagonists
NO963331D0 (no)	1996-08-09	5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister
DK1296961T3 (da)	2007-06-04	1,4-diazepan-2,5-dionderivater og anvendelse deraf som NK-1-receptorantagonister
NO20014224D0 (no)	2001-08-31	4-heterocyklysulfonamidyl-6-metoksy-5-(2-metoksy-fenoksy)-2- pyridyl-pyrimidinderivater, fremstilling derav og anvendelse somendotelin reseptor antagonister
NO992976D0 (no)	1999-06-17	Heterocykliske karboksylsyre-derivater, fremstilling og anvendelse derav som endothelinreseptor-antagonister
IL135256A0 (en)	2001-05-20	2- substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-ht1a, 5-ht1b and 5-ht1d)
IL139962A0 (en)	2002-02-10	4,5,6 and 7-indole and indoline derivatives, their preparation and use
FI971528L (fi)	1997-04-11	Pyrrolyylitetrahydrobentsokinoksaliinidionit, niiden valmistus ja käyttö glutamaattireseptoriantagonisteina
NO20011779L (no)	2001-06-07	Ureidopiperidinderivater som selektive humane NK3 reseptor antagonister
IT1304507B1 (it)	2001-03-19	Composti fotocromatici, procedimento per la loro preparazione e loroutilizzo in materiali polimerici.